Evolus Inc.

Evolus Inc. is a performance beauty company focused on the cash-pay medical aesthetics market. Evolus Inc. markets Jeuveau, a proprietary neurotoxin used by licensed aesthetic practitioners for temporary improvement in the appearance of moderate to severe frown lines, and Evolysse, a collection of injectable hyaluronic acid gel products for facial aesthetic treatment. The company serves practitioners and consumers across the United States and selected international markets, including Canada, Europe, and Australia, with a business model centered on self-pay aesthetic procedures. Evolus Inc. positions its portfolio around non-reimbursed treatments, combining product commercialization, practitioner support, and brand-led marketing within the medical aesthetics industry.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Mr. David Moatazedi

Employees

350

Headquarters

Newport Beach, CA, United States

Website

www.evolus.com